What is GoFire?
GoFire operates at the intersection of digital health and therapeutic innovation, providing a proprietary smart inhaler ecosystem integrated with a sophisticated personal dosing application. The company addresses a critical market gap by enabling patients to achieve consistent, data-backed experiences with plant-based medicines. Through the utilization of crowdsourced insights and standardized dose regimens, GoFire mitigates the risks associated with traditional administration methods. Its platform serves as a bridge between complex medicinal requirements and user-friendly wellness technology, effectively positioning the company as a leader in the emerging field of precision alternative health delivery.
How much funding has GoFire raised?
GoFire has raised a total of $399K across 2 funding rounds:
Debt
$150K
Debt
$249K
Debt (2020): $150K with participation from PPP
Debt (2021): $249K led by PPP
Key Investors in GoFire
PPP
Public-Private Partnership
Undisclosed Investors
Undisclosed Investors
What's next for GoFire?
With the recent influx of capital, GoFire is expected to scale its operational infrastructure and expand its market reach. The strategic focus will likely shift toward enhancing its data analytics capabilities and deepening its integration with clinical health resources. As the company matures, the emphasis on regulatory compliance and the standardization of patient-specific dosing will be paramount to maintaining its competitive advantage. Investors are closely monitoring how this late-stage financing will facilitate the broader adoption of its smart inhaler technology, potentially setting a new industry benchmark for safety and efficacy in the alternative medicine landscape.
See full GoFire company page
